Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 31, 2012
Pasi Janne, MD, PhD, Dana-Farber Cancer Institute, talks about a new study being presented at ASCO 2012 involving a clinical trial that shows the success of targeted therapies in one of the most common forms of lung cancers. The results could mean a treatment or place to start for treatment concerning this type of lung cancer.